Intermittent immunotherapy in patients with metastatic kidney cancer
The combination of ipilimumab/nivolumab is approved for patients as a [...]
Patient perspectives on reduced treatment schedules for immunotherapy
Immunotherapy has transformed the treatment of many cancers, including kidney [...]
Belzutifan compared to everolimus for advanced kidney cancer
People with kidney cancer have been shown to have changes (mutations) in [...]
FDA grant fast track status to CAR T cell therapy for kidney cancer
The Food and Drug Administration (FDA) in America has granted [...]
Perioperative nivolumab in intermediate/high risk kidney cancer patients
The standard of care for patients with intermediate/high risk kidney [...]
Patient perspectives on immunotherapy dosing schedules
Immunotherapy (in particular immune checkpoint inhibitors) has transformed the treatment [...]
ASCO 2024: Treatment-free survival with cabozantinib plus nivolumab
At the American Society of Clinical Oncology Annual Meeting (ASCO) last [...]
Stereotactic radiotherapy plus immunotherapy for brain metastases
Stereotactic radiosurgery (SRS) is a procedure that uses special equipment [...]
Video interview: The new cancer vaccine
We are excited to be able to show you this [...]
Treatment options in first-line metastatic kidney cancer
Over the past 10 years or so, the use of [...]
